CORRECTION article
Front. Oncol.
Sec. Molecular and Cellular Oncology
Volume 15 - 2025 | doi: 10.3389/fonc.2025.1649612
Correction: Identification of hub genes within the CCL18 signaling pathway in hepatocellular carcinoma through bioinformatics analysis
Provisionally accepted
- China Pharmaceutical University, Nanjing, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Correction on: "Identification of hub genes within the CCL18 signaling pathway in hepatocellular carcinoma through bioinformatics analysis" in volume6, 1371990.In the published article, there were errors in Figure 6. Due to carelessness during the preparation of the figure 6E and 6F, the images labeled "CCR3" in the row for "Migration, LM3, MHCC-97H", images labeled "LDHA" in the row for "Migration, LM3, MHCC-97H", images labeled "CCR3","LDHA" in the row for "Invasion, LM3", images labeled "CCR3","LDHA" in the row for "Invasion, MHCC-97H" and images labeled"Vector","CDC25C" in the row for "Invasion, MHCC-97H" show overlapping fields of view .We replaced images with the correct ones. The corrected Figure 6 and its caption appear below. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.for a reason not seen here, please contact the journal's editorial office.
Keywords: CCL18, diagnosis, Hepatocellular Carcinoma, prognostic, Tumor Microenvironment
Received: 18 Jun 2025; Accepted: 30 Jun 2025.
Copyright: © 2025 Mao, Tao, Wang, Sun, Zhang, Jin and Pan. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Liang Jin, China Pharmaceutical University, Nanjing, China
Yi Pan, China Pharmaceutical University, Nanjing, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.